Jacobs Levy Equity Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
1,091,564
+809,300
| +287% | +$995K | 0.01% | 699 |
|
|
2025
Q1 | $310K | Sell |
282,264
-1,252,404
| -82% | -$1.38M | ﹤0.01% | 974 |
|
|
2024
Q4 | $1.39M | Sell |
1,534,668
-352,844
| -19% | -$319K | ﹤0.01% | 661 |
|
|
2024
Q3 | $1.86M | Buy |
1,887,512
+442,895
| +31% | +$437K | 0.01% | 620 |
|
|
2024
Q2 | $1.3M | Sell |
1,444,617
-189,467
| -12% | -$171K | 0.01% | 677 |
|
|
2024
Q1 | $1.93M | Sell |
1,634,084
-468,964
| -22% | -$553K | 0.01% | 604 |
|
|
2023
Q4 | $1.92M | Buy |
+2,103,048
| New | +$1.92M | 0.01% | 610 |
|
|
2022
Q2 | – | Sell |
-612,496
| Closed | -$5.32M | – | 1034 |
|
|
2022
Q1 | $5.32M | Sell |
612,496
-295,936
| -33% | -$2.57M | 0.04% | 405 |
|
|
2021
Q4 | $10.3M | Sell |
908,432
-68,931
| -7% | -$780K | 0.07% | 298 |
|
|
2021
Q3 | $12.3M | Sell |
977,363
-29,116
| -3% | -$366K | 0.08% | 261 |
|
|
2021
Q2 | $8.17M | Sell |
1,006,479
-54,075
| -5% | -$439K | 0.06% | 337 |
|
|
2021
Q1 | $9.81M | Buy |
1,060,554
+429,272
| +68% | +$3.97M | 0.08% | 297 |
|
|
2020
Q4 | $6.1M | Sell |
631,282
-15,131
| -2% | -$146K | 0.05% | 362 |
|
|
2020
Q3 | $8.02M | Buy |
646,413
+383,635
| +146% | +$4.76M | 0.08% | 254 |
|
|
2020
Q2 | $3.42M | Buy |
262,778
+170,045
| +183% | +$2.21M | 0.04% | 422 |
|
|
2020
Q1 | $941K | Buy |
92,733
+11,468
| +14% | +$116K | 0.01% | 639 |
|
|
2019
Q4 | $1.27M | Buy |
+81,265
| New | +$1.27M | 0.01% | 639 |
|